Mereo BioPharma Group Plc (MREO)
0.4245
+0.05
(+13.20%)
USD |
NASDAQ |
Feb 06, 16:00
0.4299
+0.01
(+1.27%)
Pre-Market: 08:40
Mereo BioPharma Group EPS Diluted (Quarterly) : -0.0436 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Bicycle Therapeutics Plc | -0.8476 |
| GSK Plc | 0.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.982M |
| Total Expenses (Quarterly) | 6.982M |
| Enterprise Value | 19.19M |
| Earnings Yield | -62.10% |
| Normalized Earnings Yield | -62.78 |